Europe Immunochemistry Market

The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.

The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes. However, the market is likely to slower down its growth due to the shortage of skilled professionals.

The healthcare industry has been observing rapid transformations during the previous years. Various technological improvements have been witnessed in the segments such as, diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses, ageing population, are the primary factors fuelling the growth of healthcare segment.

Germany has a history of manufacturing high diagnostic imaging technologies, precision medical instruments and others. There has been an increase in the healthcare expenditure in the European countries during the previous years. As per Eurostat in 2016, healthcare expenditure in Germany was EUR 352 billion. Medical technologies is the priority of Healthcare/Life Sciences (HCT) industry. Whereas the healthcare expenditure of France was recorded as the second highest which was around EUR 257 billion, followed by the United Kingdom EUR 234 billion.

The above mentioned factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.

Germany is expected to lead the market in the Europe region owing to the factors such as an increase in the number of cancer cases, the higher prevalence of the diseases, government initiatives, and investments for the research and development by the government bodies and private entities. Along with the government, private companies are also focusing on the development of the conditions in the country. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.

Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report Request Free Sample PDF

Europe Immunochemistry Strategic Insights

Strategic insights for the Europe Immunochemistry provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Immunochemistry Report Scope

Europe Immunochemistry Regional Insights

The geographic scope of the Europe Immunochemistry refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

EUROPE IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION

By Product

• Antibodies

  • Primary Antibodies
  • Secondary Antibodies

• Equipment

  • Slide Staining Systems
  • Tissue Microarray Systems
  • Slide Scanners
  • Other Equipment

• Reagents

  • Histological Stains
  • Blocking and Fixation Reagents
  • Chromogenic Substrates
  • Stabilizers
  • Solvents
  • Proteolytic Enzymes

• Kits

By Application

• Diagnostics

  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases

• Drug Testing

By

End User

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

By Geography

• Europe
• UK
• Germany
• France
• Spain
• Italy

Company Profiles

• PerkinElmer, Inc.
• Abcam Plc
• Agilent Technologies,
• Bio SB
• Bio-Rad Laboratories, Inc.
• Cell Signalling Technology, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.